Jonathan Stroud Image

Jonathan Stroud

General Counsel

Unified Patents

Jonathan Stroud is General Counsel at Unified Patents, LLC, where he manages a growing team of talented, diverse attorneys and oversees a docket of administrative challenges, appeals, licensing, pooling, and district court work in addition to trademark, copyright, administrative, amicus, policy, marketing, and corporate matters.

Prior to Unified, he was a litigator with Finnegan, Henderson, Farabow, Garrett & Dunner LLP, and prior to that, he was a patent examiner at the USPTO. He earned his J.D. with honors from the American University Washington College of Law; his B.S. in Biomedical Engineering from Tulane University; and his M.A. in Print Journalism from the University of Southern California. He enjoys teaching, writing, and speaking on patent and administrative law.

Recent Articles by Jonathan Stroud

Patent Filings Roundup: IP Edge Hearings in Delaware Launch Fireworks; Qualcomm Claims Confirmed Unpatentable in AAPA Decision on Remand

It was a light week for patent filings, with 18 Patent Trial and Appeal Board (PTAB) and 38 district court complaints; last week saw the first Fintiv denials in months in a tranche of cases very close to trial; this week there were five more discretionary denials under Section 325(d), where the parties failed to point out any material error in earlier proceedings analyzing similar art under Advanced Bionics. And obviously, the third Fortress/VLSi trial resulting in another near-billion-dollar award splashed the headlines. The District of Delaware was busy uncovering the story behind IP Edge/Mavexar LLC and how they run and control their subsidiaries, and it’s even more interesting than I thought it was; though of course, it hasn’t stopped entities like those run by Jeffrey Gross from continuing to roll out filings. More below.

Patent Filings Roundup: Old IP Edge Filings Explode; No New Discretionary Denials Again; Fortress-Backed DivX Rolls On

It was a return to form this week in the district courts, with 115 new patent filings (led by more than 40 new IP Edge complaints) to just 23 new Patent Trial and Appeal Board (PTAB) filings—the latter number being bolstered by a number of challenges to patents held by Raymond Anthony Joao subsidiary Beteiro, LLC by a conglomerate of gambling companies, including PointsBet USA, DraftKings, Inc., BetMGM, LLC, Hillside New Jersey LLC, and Entain Corporate Services Ltd. Micron filed another set of challenges against Katana Silicon Technologies patents, Ecobee challenged another Magnetar entity, Ollnova, which has brought suit on Internet of Things (IoT) related devices; and it was another week without any discretionary denials.

Patent Filings Roundup: Another Slow Week in the Courts; Discretionary Denials Drop to Near-Zero in Q3

It was another surprisingly light week in patent filings, compared at least with recent memory—just 29 new suits and 17 new filings at the Patent Trial and Appeal Board (PTAB), all inter partes reviews (IPRs). The filings include a few challenges against patents asserted by the Fortress-funded Neo Wireless and Netlist, as well as a slew of filings by Apple against Mullin Industries, LLC. After a week’s respite there were five new IP Edge suits—not as many as usual, but still enough to represent almost a fifth of all suits filed this week.

Patent Filings Roundup: Light Week in District Court Buoyed by IV-Selloff Assertions; Vidal Grants Second Sua Sponte Review of Second Institution in OpenSky/VLSI Case

This week saw 26 Patent Trial and Appeal Board (PTAB) filings (all inter partes reviews [IPRs]) and just 28 new district court complaints—and notably and unusually, no new IP Edge filings. Most of the filings were related to three entities, the now-sprawling Bell Semiconductor campaign added a slew of new defendants, and Cedar Lane and Buffalo Patents, both campaigns comprised entirely of old Intellectual Ventures (IV) patents (both almost certainly transferred under IV’s late-stage low-cost time-limited backend deal structure). There was one (non-Fintiv) denial at the Board and a few IV patents were challenged directly by Honda; some pharmaceutical challenges were filed, but otherwise, it was a relatively quiet week in new filings, particularly in the district court (it’s the first week in as long as I can remember when there didn’t appear to be a single IP Edge filing, which certainly contributes to the lull).

Past Events with Jonathan Stroud

IPWatchdog Patent Litigation Masters™ 2022 (In-Person)

May 23 @ 9:00 am - May 24 @ 6:00 pm EDT